EFM
VERA icon

E Fund Management’s Vera Therapeutics VERA Stock Holding History

E Fund Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Sell
10,359
-2,436
-19% -$90.8K 0.01% 303
2026
Q1 		$515K Buy
+12,795
New +$551K 0.02% 288
2025
Q1 		– Sell
-6,203
Closed -$262K – 433
2024
Q4 		$262K Buy
6,203
+1,130
+22% +$50K 0.01% 333
2024
Q3 		$224K Sell
5,073
-2,322
-31% -$88.1K 0.01% 303
2024
Q2 		$268K Sell
7,395
-865
-10% -$34.3K 0.01% 250
2024
Q1 		$356K Buy
+8,260
New +$294K 0.02% 250

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

E Fund Management's VERA Position: Q2 2026 in Review

E Fund Management reduced its Vera Therapeutics (VERA) stake by 19% in Q2 2026, selling an estimated $90.8K and leaving 10,359 shares worth $445K. The position accounts for 0.01% of the portfolio, ranked #303.

E Fund Management first reported a position in VERA in Q1 2024 and has held it in 6 quarters since. The position peaked at $515K in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • E Fund Management held 10,359 shares of Vera Therapeutics worth $445K as of Q2 2026.
  • E Fund Management sold 2,436 Vera Therapeutics shares in Q2 2026, an estimated $90.8K.
  • Vera Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #303 holding.
  • E Fund Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • E Fund Management's Vera Therapeutics position peaked at $515K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.